Literature DB >> 23651058

Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.

Valeriy G Ostapchenko1, Flavio H Beraldo, Andre L S Guimarães, Sanju Mishra, Monica Guzman, Jue Fan, Vilma R Martins, Vania F Prado, Marco A M Prado.   

Abstract

Prion protein (PrP(C) ), a glycosylphosphatidylinositol-anchored protein corrupted in prion diseases, has been shown recently to interact with group I metabotropic glutamate receptors (mGluRs). Moreover, both PrP(C) and mGluRs were proposed to function as putative receptors for β-amyloid in Alzheimer's disease. PrP(C) can be processed in neurons via α or β-cleavage to produce PrP(C) fragments that are neuroprotective or toxic, respectively. We found PrP(C) α-cleavage to be 2-3 times higher in the cortex of APPswe/PS1dE9 mice, a mouse model of Alzheimer's disease. A similar age-dependent increase was observed for PrP(C) β-cleavage. Moreover, we observed considerable age-dependent increase in cortical expression of mGluR1, but not mGluR5. Exposure of cortical neuronal cultures to β-amyloid oligomers upregulated mGluR1 and PrP(C) α-cleavage, while activation of group I mGluRs increased PrP(C) shedding from the membrane, likely due to increased levels of a disintegrin and metalloprotease10, a key disintegrin for PrP(C) shedding. Interestingly, a similar increase in a disintegrin and metalloprotease10 was detected in the cortex of 9-month-old APPswe/PS1dE9 animals. Our experiments reveal novel and complex processing of PrP(C) in connection with mGluR overexpression that seems to be triggered by β-amyloid peptides. Prion protein (PrP(C) ) and metabotropic glutamate receptors (mGluR) are implicated in Alzheimer's disease (AD). We found age-dependent increase in PrP(C) processing, ADAM10 and mGluR1 levels in AD mouse model. These changes could be reproduced in cultured cortical neurons treated with Aβ peptide. Our findings suggest that increased levels of Aβ can trigger compensatory responses that may affect neuronal toxicity.
© 2013 International Society for Neurochemistry.

Entities:  

Keywords:  ADAM10; Alzheimer's disease; cellular prion protein; metabotropic glutamate receptor; prion protein processing; transgenic mouse model

Mesh:

Substances:

Year:  2013        PMID: 23651058     DOI: 10.1111/jnc.12296

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.

Authors:  Maxime Béland; Xavier Roucou
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

2.  Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms.

Authors:  Mohammed Albatany; Valeriy G Ostapchenko; Susan Meakin; Robert Bartha
Journal:  J Neurooncol       Date:  2019-08-07       Impact factor: 4.130

3.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

Review 4.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

5.  Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.

Authors:  Flavio H Beraldo; Valeriy G Ostapchenko; Fabiana A Caetano; Andre L S Guimaraes; Giulia D S Ferretti; Nathalie Daude; Lisa Bertram; Katiane O P C Nogueira; Jerson L Silva; David Westaway; Neil R Cashman; Vilma R Martins; Vania F Prado; Marco A M Prado
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

Review 6.  Fragile X and APP: a Decade in Review, a Vision for the Future.

Authors:  Cara J Westmark
Journal:  Mol Neurobiol       Date:  2018-09-17       Impact factor: 5.590

7.  Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.

Authors:  Jiang Wu; Bihua Bie; Joseph F Foss; Mohamed Naguib
Journal:  Mol Neurobiol       Date:  2020-02-01       Impact factor: 5.590

8.  The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.

Authors:  Valeriy G Ostapchenko; Megan Chen; Monica S Guzman; Yu-Feng Xie; Natalie Lavine; Jue Fan; Flavio H Beraldo; Amanda C Martyn; Jillian C Belrose; Yasuo Mori; John F MacDonald; Vania F Prado; Marco A M Prado; Michael F Jackson
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

9.  A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Authors:  Pascual Sanchez-Juan; Matthew T Bishop; Gabor G Kovacs; Miguel Calero; Yurii S Aulchenko; Anna Ladogana; Alison Boyd; Victoria Lewis; Claudia Ponto; Olga Calero; Anna Poleggi; Ángel Carracedo; Sven J van der Lee; Thomas Ströbel; Fernando Rivadeneira; Albert Hofman; Stéphane Haïk; Onofre Combarros; José Berciano; Andre G Uitterlinden; Steven J Collins; Herbert Budka; Jean-Philippe Brandel; Jean Louis Laplanche; Maurizio Pocchiari; Inga Zerr; Richard S G Knight; Robert G Will; Cornelia M van Duijn
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

Review 10.  Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders.

Authors:  Christina Gross; Gary J Bassell
Journal:  Front Mol Neurosci       Date:  2014-02-13       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.